Healthcare Stocks Under Scanner -- DaVita, Acadia Healthcare, Humana, and Align Technology

NEW YORK, December 15, 2016 /PRNewswire/ --

For today, Stock-Callers.com directs investors' attention to DaVita Inc. (NYSE: DVA), Acadia Healthcare Co. Inc. (NASDAQ: ACHC), Humana Inc. (NYSE: HUM), and Align Technology Inc. (NASDAQ: ALGN). These companies belong to the Healthcare sector which was lower just before the closing bell on Wednesday, December 14^th, 2016. As per an article on the NASDAQ, the NYSE Health Care Index fell about 0.5%, while shares of health care companies in the S&P 500 declined about 0.5% as a group. You can access of our complimentary research reports on these stocks now at:

http://stock-callers.com/registration

DaVita 

Denver, Colorado headquartered DaVita Inc.'s shares saw a drop of 2.40%, finishing Wednesday's trading session at $63.80. A total volume of 3.65 million shares was traded, which was above their three months average volume of 2.27 million shares. In the last one month, the stock has advanced 5.30%. The Company's shares are trading above their 50-day moving average by 3.44%. Moreover, shares of DaVita, which provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease, have a Relative Strength Index (RSI) of 51.27.

On December 02^nd, 2016, DaVita formally announced the launch of a new joint venture with Inspira Health Network to enhance and expand dialysis services in South Jersey. The new entity will provide quality services at three centers in Bridgeton, Millville and Vineland.

On December 13^th, 2016, research firm Robert W. Baird downgraded the Company's stock rating from 'Outperform' to 'Neutral'. The research firm revised upwards its previous target price from $68 to $69. Visit us today and download your complete report on DVA for free at:

http://stock-callers.com/registration/?symbol=DVA

Acadia Healthcare 

On Wednesday, shares in Franklin, Tennessee headquartered Acadia Healthcare Co. Inc. recorded a trading volume of 2.69 million shares, which was above their three months average volume of 1.38 million shares. The stock ended the session 3.73% lower at $33.31. The Company's shares are trading 16.17% below their 50-day moving average. Furthermore, shares of Acadia Healthcare, which develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the US, the UK, and Puerto Rico, have an RSI of 27.01.

On November 30^th, 2016, Acadia Healthcare announced that it has completed its previously announced sale to funds advised by BC Partners LLP of 21 existing behavioral health facilities and one de novo behavioral health facility, not yet opened, in the UK for £320 million ($395 million) cash. The sale fulfills the undertakings Acadia gave the Competition and Markets Authority ("CMA") in the UK to address the CMA's concerns about the impact of Acadia's acquisition of Priory on competition for the provision of behavioral healthcare services in certain markets in the UK.

On December 02^nd, 2016, research firm Jefferies resumed its 'Buy' rating on the Company's stock. The complimentary research report on ACHC can be accessed at:

http://stock-callers.com/registration/?symbol=ACHC

Humana 

Shares in Louisville, Kentucky headquartered Humana Inc. closed at $205.24, up 0.33% from the last trading session. The stock recorded a trading volume of 1.11 million shares. The Company's shares have gained 3.22% in the last one month, 17.62% in the previous three months, and 15.53% on an YTD basis. The stock is trading 9.22% above its 50-day moving average and 14.53% above its 200-day moving average. Additionally, shares of Humana, which together with its subsidiaries, operates as a health and well-being company, have an RSI of 58.77.

On December 07^th, 2016, research firm Cantor Fitzgerald downgraded the Company's stock rating from 'Buy' to 'Hold'.

On December 14^th, 2016, Humana announced that it has implemented a Clinical Quality Metrics Alignment program to streamline and standardize the set of clinical quality metrics used for physicians. The program will support physicians who are participating in value-based payment relationships with Humana. Register for free on Stock-Callers.com and download the PDF research report on HUM at:

http://stock-callers.com/registration/?symbol=HUM

Align Technology 

At the closing bell yesterday, shares in San Jose, California headquartered Align Technology Inc. ended 0.55% lower at $98.60, with a total trading volume of 725,191 shares. The stock has advanced 9.29% in the last one month, 6.10% over the previous three months, and 49.73% since the start of this year. The Company's shares are trading above their 50-day and 200-day moving averages by 7.73% and 17.16%, respectively. Furthermore, shares of Align Technology, which designs, manufactures, and markets a system of clear aligner therapy, intra-oral scanners, and computer-aided design and computer-aided manufacturing digital services for use in dentistry, orthodontics, and dental records storage in the US and internationally, have an RSI of 62.32.

On November 28^th, 2016, research firm Stifel reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $95 to $110. Get free access to your research report on ALGN at:

http://stock-callers.com/registration/?symbol=ALGN

--

Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://stock-callers.com/legal-disclaimer/

CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number:  +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA